Ovid partners with Waksal startup to develop drugs for rare brain disorders

Ovid partners with Waksal startup to develop drugs for rare brain disorders

Source: 
BioPharma Dive
snippet: 

Ovid Therapeutics is partnering with privately held biotechnology startup Graviton Bioscience to develop drugs for rare brain disorders with few or no other treatment options.